References
- Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for diagnosis, management, and prevention of COPD Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.htmlAccessed December 6, 2014
- FukahoriSMatsuseHTakamuraNPrevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVCInt J Clin Pract200963226927419196365
- AaronSDVandemheenKLFergussonDCanadian Thoracic Society/Canadian Respiratory Clinical Research Consortium. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trialAnn Intern Med2007146854555517310045
- PerngDWWuCCSuKCLeeYCPerngRPTaoCWAdditive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroidsRespirology200611559860216916333
- SinghDBrooksJHaganGCahnAO’ConnorBJSuperiority of triple therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPDThorax200863759259818245142
- WelteTMiravitllesMHernandezPEfficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009180874175019644045
- ChatterjeeAShahMD’SouzaAOBechtelBCraterGDalalAAObservational study on the impact of initiating tiotropium alone versus tiotropium with fluticasone propionate/salmeterol combination therapy on outcomes and costs in chronic obstructive pulmonary diseaseRespir Res2012131522340019
- RodrigoGJPlazaVCastro-RodríguezJAComparison of three combined pharmacological approaches with tiotropium monotherapy in stable moderate to severe COPD: a systematic reviewPulm Pharmacol Ther2012251404722085775
- CazzolaMMateraMGTriple combinations in chronic obstructive pulmonary disease – is three better than two?Expert Opin Pharmacother201415172475247825327264
- MiyazakiMNakamuraHChubachiSAnalysis of comorbid factors that increase the COPD assessment test scoresRespir Res2014151324502760
- ChubachiSNakamuraHSasakiMPolymorphism of low-density lipoprotein receptor-related protein 5 gene and emphysema severity are associated with osteoporosis in Japanese patients with or at risk for COPDRespirology Epub20141112
- JonesPWHardingGBerryPWiklundIChenWHLeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
- WurstKEPunekarYSShuklaATreatment evolution after COPD diagnosis in the UK primary care settingPLoS One201499e10529625180802
- PriceDWestDBrusselleGManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patternsInt J Chron Obstruct Pulmon Dis2014988990525210450
- KoblizekVPecenLZatloukalJReal-life GOLD 2011 implementation: the management of COPD lacks correct classification and adequate treatmentPLoS One2014911e11107825380287
- ParkSJMakeBHershCPBowlerRPSignificance of medication history at the time of entry into the COPDGene study: relationship with exacerbation and CT metricsCOPD Epub2014925
- MagnussenHDisseBRodriguez-RoisinRWithdrawal of inhaled glucocorticoids and exacerbations of COPDN Engl J Med2014371141285129425196117
- MarshSETraversJWeatherallMProportional classifications of COPD phenotypesThorax200863976176718728201
- FabbriLMRomagnoliMCorbettaLDifferences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2003167341842412426229
- NishimuraMMakitaHNagaiKAnnual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20121851445222016444
- KimSRRheeYKOverlap between asthma and COPD: where the two diseases convergeAllergy Asthma Immunol Res20102420921420885905
- SuzukiMMakitaHItoYMClinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort studyEur Respir J20144351289129724232696
- FlynnRWMacDonaldTMHapcaAMacKenzieISSchembriSQuantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysisRespir Res20141514125407604
- MakitaHNasuharaYNagaiKCharacterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary diseaseThorax2007621193293717573447
- TanabeNMuroSHiraiTImpact of exacerbations on emphysema progression in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2011183121653165921471102
- BetsuyakuTKatoMFujimotoKA study to assess COPD symptom- based management and to optimise treatment strategy in Japan (COSMOS-J) based on GOLD 2011Int J Chron Obstruct Pulmon Dis2013845345924124358